Werewolf Therapeutics, Inc. (HOWL) Form 8-K Summary
Werewolf Therapeutics filed this Form 8-K on November 4, 2025, primarily to report financial results.
- Material Event: The company issued a press release announcing financial results for the quarter ended September 30, 2025 (Exhibit 99.1).
- Investor Action: Investors must review Exhibit 99.1 for specific financial metrics, performance data, and cash runway details, as the 8-K body only references the release.
- Status: The company remains an Emerging Growth Company and has elected not to use extended transiti